New insights into a population of tumor-infiltrating T cells may ultimately allow doctors to predict how patients will respond to checkpoint blockade immunotherapy, a form of cancer treatment with advantages that doctors ...
Researchers from the Department of Molecular Biology and Genetics at Koc University in Turkey and the Pole of Endocrinology, Diabetology and Nutrition, Institute of Experimental and Clinical Research at Université Catholique ...
Annual screenings of patients at high risk for lung cancer can catch tumors early and improve a patient's long-term prognosis. However, low-dose computer tomography (LDCT) has a high false-positive rate that can lead to unnecessary ...
Jul 13, 2022
0
5
A pill has been shown to halve the risk of death from a certain type of lung cancer when taken daily after surgery to remove the tumor, according to clinical trial results presented on Sunday.
Jun 5, 2023
0
91
Immunotherapy—drug treatment that stimulates the immune system to attack tumors—works well against some types of cancer, but it has shown mixed success against lung cancer.
Feb 2, 2023
0
77
Intense light activates proteins shown to protect against lung damage in mice, a discovery that could have major therapeutic implications for treating acute lung injury in humans, according to a new study from researchers ...
Mar 24, 2022
0
9
A new study by Tulane University has uncovered a previously unknown molecular pathway that could be instrumental to halting lung cancer in its tracks.
Nov 27, 2023
0
87
Melbourne researchers have discovered that cancer and immune cells rely on the same energy sources from our body to thrive, which could trigger a fundamental rethink of treatment options for some lung cancer patients.
Jun 30, 2022
0
40
A drug that is commonly used to treat tapeworm infections might help to prevent the formation of atypical fused cells in the lungs of patients with COVID-19, according to laboratory experiments reported this week in Nature.
Apr 8, 2021
0
7
MIT cancer biologists have identified a new therapeutic target for small cell lung cancer, an especially aggressive form of lung cancer with limited options for treatment.
Nov 7, 2019
0
80
